Nachrichten zur Johnson Matthey PLC Aktie

Johnson & Johnson Aktie: Jahresprognose angehoben

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI):Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI),…

J&J to spin off orthopedics business, sees 2026 sales growth of over 5%

Johnson & Johnson on Tuesday said it plans to separate its orthopedics business into a standalone company named DePuy Synthes.…

ROUNDUP: Johnson & Johnson hebt Umsatzziel erneut an - Trennung von Orthopädie

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) setzt sich nach einem überraschend guten dritten Quartal abermals höhere…

Big Money Move: Investment Manager Buys $6.9 Million Worth of Johnson & Johnson Shares, According to Recent Filing

Key PointsBought 40,238 JNJ shares; estimated $6.89 million trade based on average pricing for Q3 2025Post-trade holding: 103,832 shares valued…

Best Healthcare Stocks To Keep An Eye On

UnitedHealth Group, Johnson & Johnson, and Hims & Hers Health are the three Healthcare stocks to watch today, according…

Q3 Earnings Season Setup Remains Favorable: What to Know

The big banks dominate this weeks reporting docket, but we also have several bellwethers from other sectors reporting, including Johnson…

Johnson & Johnson in talks to acquire Protagonist Therapeutics, WSJ reports By Reuters

Johnson & Johnson in talks to acquire Protagonist Therapeutics, WSJ reports…

Johnson & Johnson in talks to acquire Protagonist Therapeutics, WSJ reports

Johnson & Johnson is in discussions to buy Protagonist Therapeutics , the Wall Street Journal reported on Friday, citing people…

Johnson & Johnson Aktie: Dauerläufer gibt wieder Gas - Chartanalyse

Düsseldorf (www.aktiencheck.de) - Johnson & Johnson-Chartanalyse von HSBC Trinkaus & Burkhardt:Die Analysten von HSBC Trinkaus & Burkhardt nehmen in einer…

Why Johnson & Johnson (JNJ) is Poised to Beat Earnings Estimates Again

Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…

Goldman Sachs expects another quarter of outperformance from J&J in Q3

Johnson & Johnson (NYSE:JNJ)’s strong year-to-date performance is likely to continue when the healthcare giant reports third quarter earnings on…

Is Johnson Matthey (JMPLY) Stock Outpacing Its Basic Materials Peers This Year?

Here is how Johnson Matthey PLC (JMPLY) and Alamos Gold (AGI) have performed compared to their sector so far this…

Top Analyst Reports for Microsoft, Amazon.com & Johnson & Johnson

Microsoft rides AI and cloud growth, Amazon leans on AWS and Prime, and Johnson & Johnson gains from strong pharma…

Johnson & Johnson Aktie: Neue Bewertung! Das sagt BofA zum Biopharma-Riesen

Charlotte (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von BofA Securities:Die Analysten von BofA Securities haben das Kursziel für Johnson & Johnson…

Johnson & Johnson (JNJ) Rises Higher Than Market: Key Facts

Johnson & Johnson (JNJ) closed the most recent trading day at $188.64, moving +1.43% from the previous trading session.…

Here are Fridays biggest analyst calls: Nvidia, Apple, Broadcom, Tesla, Netflix, Ferrari, Johnson & Johnson, Coinbase and more

Here are Fridays biggest calls on Wall Street.…

Johnson & Johnson is a buy as drug sales continue to improve, Wells Fargo says

The bank upgraded the pharma giant to overweight from equal weight.…

Johnson & Johnson Aktie: Pharma-Upside in Sicht - Upgrade auf "overweight" - Kursziel auf 212 USD erhöht

San Francisco (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Wells Fargo:Larry Biegelsen, Analyst von Wells Fargo, stuft die Aktie von Johnson…

Johnson & Johnson: Vom Dampfer zum Rennboot - Geringe Volatilität, volle Kraft voraus!

Gesundheitsriese gibt Gas! Rückblick Der weltweit größte Hersteller von Gesundheitsprodukten mit Hauptsitz in New Brunswick ist ein etabliertes Unternehmen mit…

Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth Knowing

Johnson & Johnson (JNJ) closed at $179.71 in the latest trading session, marking a +1.11% move from the prior day.…

Johnson & Johnson (JNJ) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what…

Johnson & Johnson Aktie: Klare Wende in der Einschätzung - Guggenheim Securities rät nun zum Kauf

Bad Marienberg (www.aktiencheck.de) - Johnson & Johnson : Guggenheim Securities hebt Rating auf "buy" – Kursziel 206 USD nach großer…

Take the Zacks Approach to Beat the Market: LendingTree, AutoZone, J&J in Focus

Zacks highlights winners like LendingTree, AutoZone, and Johnson & Johnson as its proven stock-picking strategies continue to shine.…

Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts

Johnson & Johnson (JNJ) reached $174.16 at the closing of the latest trading day, reflecting a -1.72% change compared to…

Johnson & Johnson: Der alte Dampfer liefert ab

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI): Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda

The United States Pharmaceutical Market is projected to reach $979.25 billion by 2033, from $638.86 billion in 2024, at a…

Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Why Johnson & Johnson Stock Still Has Room To Run

…

Eli Lilly, Pfizer und Johnson & Johnson im Visier der US-Regierung und auch Novo Nordisk hat momentan wenig zu lachen

Das Geschäftsmodell der großen Pharmakonzerne ist nicht nur weitgehend krisensicher, sondern auch enorm lukrativ. Zu verdanken ist dies zu nicht…

What Is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill.

Key PointsReliability is one of the most important things about a dividend.Johnson & Johnson is a Dividend King with an…

JNJ Seeks FDA Approval for Oral Psoriasis Drug Icotrokinra

Johnson & Johnson eyes FDA nod to icotrokinra after phase III studies show strong skin clearance and safety in plaque…

Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Spravato sales momentum underscores market potential for psychedelics, atai Life Sciences seen as key beneficiary

Sales of Johnson & Johnson (NYSE:JNJ)’s esketamine nasal spray Spravato grew sequentially in the second quarter, marking a positive sign for…

Johnson & Johnson Aktie: Wachstum bei "Innovative Medicine" dürfte Prognosen übertreffen

San Francisco (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Wells Fargo Advisors: Die Analysten von Wells Fargo haben das Rating "equal-weight" und…

Johnson & Johnson: The Worst Is Baked In

…

Johnson & Johnson Aktie: Morgan Stanley erhöht Kursziel - aber kein Kauf?

Bad Marienberg (www.aktiencheck.de) - Johnson & Johnson: Kursziel steigt auf 176 USD – Analyst bleibt dennoch zurückhaltend Die Investmentbank Morgan Stanley…

Johnson & Johnsons Healthy 3.3%-Yielding Dividend Is a Very Safe Way to Make Passive Income

Key PointsJohnson & Johnson continues to generate plenty of free cash flow to cover its dividend. The healthcare giant also…

Is Johnson & Johnson a Good Dividend Stock to Buy Now? @themotleyfool #stocks $JNJ

…

3 Top Dividend Stocks Yielding More Than 3% That You Shouldnt Hesitate to Buy Right Now

Key PointsExxonMobil has the best dividend growth track record in the oil industry. Johnson & Johnson has increased its dividend…

Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript

…

Johnson & Johnson (JNJ) Q2 Earnings and Revenues Top Estimates

Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +4.14% and +4.13%, respectively, for the quarter ended June 2025.…

Johnson & Johnson (JNJ) Surpasses Q2 Earnings and Revenue Estimates

Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +4.14% and +4.13%, respectively, for the quarter ended June 2025.…

Why Johnson & Johnson Rallied Today

Key PointsJohnson & Johnson delivered a "beat and raise" quarter. Results were bolstered by the new acquisition of Intra-Cellular, marking…

Dows 110-point rally highlighted by gains in Johnson & Johnson, Amgen shares

The Dow Jones Industrial Average is up Wednesday afternoon with shares of Johnson & Johnson and Amgen seeing positive momentum…

Stocks making the biggest moves midday: Morgan Stanley, ASML, Johnson & Johnson, SolarEdge and more

These are the stocks posting the largest moves in midday trading.…

Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool. DATEWednesday, July 16, 2025 at 8:30 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Joaquin DuatoChief…

Wall Street: Nvidia und Johnson & Johnson stehen zum Auftakt im Fokus

Die US-Börsen zeigen sich am Mittwoch uneinheitlich: Während der Dow Jones oder 0,3 Prozent zulegt und der S&P 500 um…

Wall Street: Nvidia und Johnson & Johnson stehen zum Auftakt im Fokus

Die US-Börsen zeigen sich am Mittwoch uneinheitlich: Während der Dow Jones oder 0,3 Prozent zulegt und der S&P 500 um…

Market movers: Johnson & Johnson, Morgan Stanley, Bit Digital...

…